At the news
? MIXEDIMPACT 6/10 8-K filed May 13, 2026 at 16:06 ET
Omeros reported Q1 2026 results with first-ever YARTEMLEA commercial sales of $9.9M net, GAAP net income of $56.1M (vs a $33.5M loss a year ago), and non-GAAP adjusted net loss of $17.1M ($0.24/share) that beat consensus of -$0.28. Revenue slightly missed $10.1M consensus. CMS assigned a J-code effective July 1 and recommended NTAP, signaling improving reimbursement.
- First YARTEMLEA net sales of $9.9M in Q1 2026 (launched Jan 2026)
- GAAP net income $56.1M vs net loss of $33.5M in Q1 2025
- Non-GAAP adjusted net loss $17.1M ($0.24/share) beat consensus $-0.28
- Revenue $9.9M vs consensus $10.1M (miss of ~2%)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access